Health
Phycobilins found to inhibit SARS-CoV-2 enzymes in vitro – News-Medical.Net
Researchers have released an interesting new study that describes the broad-spectrum of antiviral activity that phycobilins can have. Phycobilins, which are bioactive…
The search for effective antivirals to counter or prevent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the pathogen that causes coronavirus disease 2019 (COVID-19), continues.
Researchers from Tennesee State University and Meharry Medical College in the United States have released an interesting new study on the preprint bioRxiv* server in November 2020 that describes the broad-spectrum of antiviral activity that phycobilins can have. Phycobilins, which are bioactive plant…
-
Business21 hours agoMacquarie tips 14% upside for this ASX tech stock
-
Noosa News17 hours agoWilliam Robinson dies aged 89
-
Business18 hours agoTop brokers name 3 ASX shares to buy today 27 August 2025
-
Business21 hours agoThis ASX 200 media stock is storming 7% higher to 52-week highs. Here’s why.